THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Compulink announces agreement to acquire Eyecom, a division of Echo, a HealthStream Company. Company continues to increase its share of optometric EHR market.
Uncategorized
First patient enrolled in ThromboGenics’ Phase II CIRCLE study of ocriplasmin in NPDR patients
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the eff…
New clinical study reveals previously unknown risk factors linked to keratoconus
A large new study reveals previously unknown risk factors associated with an eye condition that causes serious progressive nearsightedness at a relatively young age.
Uncategorized
Baerveldt implantation, trabeculectomy yield similar results after primary glaucoma surgery
Baerveldt implantation and trabeculectomy with mitomycin C may have similar surgical success rates in primary incisional glaucoma surgery, according to a study.The retrospective, comparative case series reviewed 125 low-risk glaucoma cases with no prio…
Glaukos Provides Preliminary Fourth Quarter and Full Year 2015 Net Sales and Full Year 2016 Net Sales Guidance
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
Uncategorized
Researchers identify genetic associations that influence primary open angle glaucoma
Investigators have identified three genetic associations – TXNRD2, ATXN2 and FOXC1 – that may influence susceptibility of primary open angle glaucoma, according to a press release from Massachusetts Eye and Ear/Harvard Medical School and Case Western Reserve University School of Medicine.The findings, published in Nature Genetics, are intended to be used to develop gene-based testing and treatment strategies for glaucoma.